SCHEMBL24414633

SCHEMBL24414633

NCc1ccc2ccn(CC(N)=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
KMT2A Q03164 1/20 0.41
ROCK2 O75116 3/20 0.41
HDAC8 Q9BY41 2/20 0.40
KMO O15229 1/20 0.39
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 4/20 0.39
HPGD P15428 4/20 0.39
TSHR P16473 3/20 0.39
GLA P06280 1/20 0.39
HTT P42858 1/20 0.39
POLB P06746 2/20 0.39
APOBEC3A P31941 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
F2 P00734 1/20 0.38
F10 P00742 1/20 0.38
PRSS1 P07477 1/20 0.38
HDAC3 O15379 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30991849 1.00 LMNA (0.42) LMNAKMT2AROCK2HDAC8KMO
SCHEMBL3353214 0.81 LMNA (0.44) LMNAKMT2AROCK2KMOKDM4E
SCHEMBL31177216 0.79 HTR2C (0.55) LMNAKMT2AKMOKDM4EALDH1A1
SCHEMBL29958565 0.79 KMO (0.61) LMNAKMT2AKMOKDM4EALDH1A1
SCHEMBL2006476 0.79 KMO (0.61) LMNAKMT2AKMOKDM4EALDH1A1
SCHEMBL13293373 0.79 ROCK2 (0.54) ROCK2ALDH1A1HTTPOLBSMN1; SMN2
SCHEMBL29208366 0.76 HDAC8 (0.47) HDAC8F2F10PRSS1HDAC3
SCHEMBL6099343 0.76 MTNR1A (0.60) KMT2AHDAC8KDM4EALDH1A1HSD17B10
SCHEMBL1520652 0.76 ALDH1A1 (0.60) LMNAKMT2AKMOKDM4EALDH1A1
SCHEMBL30991824 0.75 BACE1 (0.49) HDAC8ALDH1A1HPGDTSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281099-B2 Isoindolinone substituted indoles and derivatives as RAS inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-04-22 US disclosed
EP-3931188-B1 NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2023-08-30 EP disclosed
EP-3931188-B1 NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2023-08-30 EP disclosed
US-20220144810-A1 NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-12 US disclosed
US-20220144810-A1 NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-12 US disclosed
CN-113474340-A Novel isoindolinone substituted indoles and derivatives as RAS inhibitors 勃林格殷格翰国际有限公司 2021-10-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12281099-B2 Isoindolinone substituted indoles and derivatives as RAS inhibitors NRAS, KRAS, RASSF5 LMNA 3371/4885KMT2A 3406/4885ROCK2 484/4885
US-20220144810-A1 NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS NRAS, RASSF5, KRAS LMNA 3705/4885KMT2A 3623/4885ROCK2 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.